Assoc. Prof. MD. Erkan Kayıkçıoğlu

Education and Specialization

• Hacettepe University, Faculty of Medicine
• Specialization in Internal Medicine: Selçuk University Meram Faculty of Medicine
• Specialization in Medical Oncology: Antalya Training and Research Hospital

Experience

• 2010–2013 Seydişehir State Hospital, Internal Medicine Specialist
• 2013–2015 Antalya Private Yaşam Hospital, Internal Medicine Specialist
• 2015–2018 University of Health Sciences Antalya Training and Research Hospital, Medical Oncology Subspecialty Resident
• 2018–2020 Recep Tayyip Erdoğan University, Faculty of Medicine, Medical Oncology Specialist
• 2020–2021 University of Health Sciences Antalya Training and Research Hospital, Medical Oncology Specialist
• 2021–2023 Süleyman Demirel University, Faculty of Medicine, Assistant Professor
• 2023 Beylikdüzü Kolan Hospital

Foreign Language

• English

Clinical Studies

• Cancer Genetics

Professional Memberships

• 2022 European Society for Medical Oncology
• 2015 Turkish Society of Medical Oncology

Courses and Certificates

• 30.03.2021 Good Clinical Practice – Advanced, Türkiye, International Certificate No: 555034
• 30.03.2021 Good Clinical Practice, Türkiye, International Certificate

Articles Published in Peer-Reviewed Journals

• Kayıkçıoğlu E, Demir A (2022). The Frequency and Coexistence of Functional Gastrointestinal Disorders Among Healthcare Workers at Selçuk University Meram Faculty of Medicine According to Rome III Criteria. Turkish Journal of Clinics and Laboratory, 13(4), 433–438. doi: 10.18663/TJCL.788057.
• Kayıkçıoğlu E (2022). Demographic and Clinical Characteristics of Colon Cancer Patients in the Isparta-Burdur Region. Medical Journal of Suleyman Demirel University, 29(3), 386–389. doi: 10.17343/SDUTFD.1104209.
• Üner S, Vaizoğlu S.A., Alp S.A., Simavlı H., Maunsour N., El-Hatou H., Neprevista E., Kayıkçıoğlu E., Güler Ç. (2007). Evaluation of High School Students’ Knowledge and Attitudes Regarding Consumer Rights. Toplum Hekimliği Bülteni, 26(2), 16–21.
• Kayıkçıoğlu E, Yüceer R.O. (2023). The Role of Claudin 18.2 and HER-2 in Pancreatic Cancer Outcomes. Medicine (Ovid Technologies, Wolters Kluwer Health), 102(6). doi: 10.1097/MD.0000000000032882.
• Kayıkçıoğlu E, Yüceer R.O., Çetin B., Yüceer K., Karahan N. (2023). Prognostic Value of Claudin 18.2 Expression in Gastric Adenocarcinoma. World Journal of Gastrointestinal Oncology, 15(2), 343–351. doi: 10.4251/WJGO.V15.I2.343.
• Karaçin C, Oksuzoglu B, Demirci A, et al. (2023). Efficacy of Subsequent Treatments in Patients With Hormone-Positive Advanced Breast Cancer Who Had Disease Progression Under CDK 4/6 Inhibitor Therapy. BMC Cancer, 23(1), 192. doi: 10.1186/S12885-023-10609-8.
• Kayıkçıoğlu E, İşcan G. (2023). A Novel Prognostic Index for Metastatic Colon Cancer: The Prognostic Immune Nutritional Index. Cureus, 15(1). doi: 10.7759/Cureus.33808.
• Kayıkçıoğlu E, Önder A.H., Cetin F.B., İnal G. (2023). The Efficacy of Pazopanib in Ewing Sarcoma. Chronicles of Precision Medical Researchers, 4(1), 117–118. doi: 10.5281/Zenodo.7709543.
• Kayıkçıoğlu E, Önder A.H. (2022). The Pan-Immune-Inflammation Value Predicts the Survival of Patients With ER-Positive, HER-2-Negative Metastatic Breast Cancer Treated With CDK4/6 Inhibitors. Chronicles of Precision Medical Researchers, 3(3), 145–149. doi: 10.5281/Zenodo.7195780.
• Kayıkçıoğlu E, Aydın A.A. (2022). Prognostic Value of Clinicopathological Characteristics of Patients With Malignant Mesothelioma in the Mediterranean Region of Turkey. Çağdaş Tıp Dergisi: Journal of Contemporary Medicine, 12(6), 1002–1006. doi: 10.16899/JCM.1173730.
• Kayıkçıoğlu E, Findos E. (2022). The Prognostic Immune Nutritional Index as a Predictive Biomarker in Metastatic Castration-Resistant Prostate Cancer Treated With Abiraterone or Enzalutamide. The Injector, 1(3), 106–114. doi: 10.5281/Zenodo.7331456.
• Aydın A.A., Alparslan A.Ş., Ayık H., Kayıkçıoğlu E, Ozturk B. (2018). A Challenging Palliation via Novel Therapeutic Approach for Unusual Gingival Metastasis From Renal Cell Carcinoma Relapsed Eight Years After Nephrectomy. The European Research Journal, 4(4), 416–420. doi: 10.18621/EURJ.348318.
• Önder A.H., Ozturk B., Tatlı A.M., Kayıkçıoğlu E. (2018). Acute Pancreatitis Linked to Bevacizumab: A Case Report. Journal of Oncological Sciences (JOS), 4, 108–110. doi: 10.1016/J.JONS.2018.03.004.
• Aydın A.A., Çetin F.B., Kayıkçıoğlu E, Ozturk B., Yildiz M. (2017). A Unique Case of Malignant Pleural Mesothelioma Presenting With Highly Aggressive Multiple Brain Metastases After a Long Disease-Free Period. Cumhuriyet Medical Journal, 39(3), 624–628. doi: 10.7197/223.V39I31705.347463.
• Kayıkçıoğlu E, Aydın A.A., Önder A.H., Sayiner A., Süren D., Ozturk B. (2017). An Extremely Rare Neoplasm, Histiocytic Sarcoma: A Report of Two Cases With an Aggressive Clinical Course. Journal of Oncological Sciences (JOS), 3, 84–86. doi: 10.1016/J.JONS.2017.05.007.
• Albayrak A, Düzenli T, Kayıkçıoğlu E. (2023). Potential Drug–Drug Interactions in Patients With Non-Small Cell Lung Cancer at a University Hospital in Turkey. Journal of Cancer Research and Clinical Oncology, 149(12):9621–9627. doi: 10.1007/S00432-023-04890-0.
• Sevgilioglu Z.E., Evrimler S., Iscan G., Kayikcioglu E., Sengul S.S., Cetin B. (2023). Prognostic Value of Computed Tomography Associated Body Composition Measurement Changes in Metastatic Colorectal Cancer Patients. Acta Radiologica, doi: 10.1177/02841851231198345.

Conference Papers and Abstracts

• Kayıkçıoğlu E, Ayyıldız V.A., Evrimler Ş., Döngel İ., Çetin B. (2021). Myasthenia Gravis and Treatment Response in a Case of Pleural Thymoma Following COVID-19 Infection. 5th National Immunotherapy and Oncology Congress, Abstract B-751-8986.
• Kayıkçıoğlu E, Çetin B. (2021). A Rare Entity: Giant Cell Tumor of the Mandibular Bone. 5th National Immunotherapy and Oncology Congress, Abstract B-820-1188.
• Olgun N.V., Kayıkçıoğlu E, Bozkurt K.K., Bacak B., Gümüşay Ö., Çetin B. (2021). Prognostic Importance of WBP2 Expression in HER2-Positive Breast Cancer Patients Receiving Trastuzumab-Based Therapy at Süleyman Demirel University Faculty of Medicine Medical Oncology Unit. 5th National Immunotherapy and Oncology Congress.
• Karaman E., Kayıkçıoğlu E. (2019). The Significance of the Preoperative FDG PET-CT SUV Max Value on Disease Recurrence in Operated NSCLC Patients. 3rd National Immunotherapy and Oncology Congress, 3(1).
• Kayıkçıoğlu E, Bacık Y.G. (2023). Psychological Symptoms, Death Anxiety and Anger in Elderly Patients With Cancer. 6th Health Sciences and Life Congress.
• Kayıkçıoğlu E. (2023). Awareness of Cervical Cancer Risk Factors and Screening Methods Among Female Relatives of Cancer Patients. International Eurasia Congress.
• Kayıkçıoğlu E. (2023). Colon Cancer Awareness Among Male Relatives of Cancer Patients. 10th International Gevher Nesibe Medical Sciences Conference.
• Bacık Y.G., Kayıkçıoğlu E. (2022). The Relationship Between Perceived Stress, Emotion Regulation, and Attachment Styles in Cancer Patients. 4th International Scientific Research and Innovation Congress.

Book Chapters

• Kayıkçıoğlu E, Çetin B. (2022). Hereditary Gynecological Cancers and the Role of Molecular Pathology in Prognosis and Treatment. Chapter: DNA Damage Repair Mechanisms and Emerging Targeted Agents. Turkiye Klinikleri Gynecology Obstetrics - Special Topics. Editor: Ünal O., ISBN: 978-625-401-840-4.
• Kaya A., Kayıkçıoğlu E. (2007). MEN Syndrome Mixed Types and Confusions Between MEN1 and MEN2. In: Turkiye Klinikleri Journal of Internal Medical Sciences. Editor: Bahçeci M., ISBN: 000000000.
• Kayıkçıoğlu E. (2023). Chapter: Immunotherapy Agents Used in Medical Oncology. In: Onkolojide Güncel Tedavi Yaklaşımları 2. Akademisyen Kitabevi A.Ş., Editors: Fatih Köse, Ali Murat Sedef. ISBN: 978-605-258-373-9.
• Kayıkçıoğlu E. (2022). Chapter: Tracheal Tumors. In: Nadir Tümörler. Akademisyen Kitabevi A.Ş., Editor: Ali Murat Sedef. ISBN: 978-625-8259-58-2.
• Kayıkçıoğlu E. (2019). Chapter: Systemic Therapy in Triple-Negative Early-Stage Breast Cancer. In: Meme Kanseri. Akademisyen Kitabevi A.Ş., Editors: Özgür Özyılkan, Ali Murat Sedef, Hüseyin Özgür Aytaç, Ozan Cem Güler. ISBN: 978-605-258-550-4.